Summary

Intra-Aortic Balloon Pump (IABP) Market
The intra-aortic balloon pump (IABP) market was valued at $351.2 million in 2023 and is projected to reach $528.2 million by 2033, growing at a CAGR of 4.2% from 2024 to 2033.
An intra-aortic balloon pump (IABP) is a provisional medical equipment used to pump more blood into the heart at times when it is unable to function adequately. It is a cylindrical balloon developed from polyurethane that sits in the aorta to perform inflation and deflation. IABP is crucial for individuals suffering from cardiogenic shock that typically arises from conditions such as heart failure, unstable angina, heart attack, and certain arrhythmias.

Factors such as exponentially increasing geriatric population and stationary lifestyles have upsurged the prevalence of cardiovascular diseases, propelling the development of the intra-aortic balloon pump (IABP) market. In addition, rise in the deployment of IABP in interventional cardiology procedures such as percutaneous coronary interventions augments the development of the market. The assimilation of technological innovations into the equipment is a key trend gaining prominence in the intra-aortic balloon pump (IABP) market. Manufacturers are focusing on the development of novel models of IABPs with automated control, battery-powered mobility, and small sizes to enhance their safety & efficiency.

However, the temporary effectiveness of IABPs leads to stringent competition from enduring equipment such as ventricular assist devices. Such devices limit the usage of IABPs and restrain the development of the market. Furthermore, the possibility of complications arising due to IABP entrapment discourages its usage, hampering the market growth significantly. For instance, a case series published by the Taylor & Francis Group—a commercial publishing company—stated that thrombocytopenia and fever are the common complications of entrapped IABP, occurring around 50 and 36% of the time. Moreover, intricacies such as vascular tears and limb ischemia exhibit a 1–2% possibility of occurrence in individuals. On the contrary, rise in expenditure on healthcare infrastructure to develop cutting-edge medical equipment is poised to present lucrative opportunities for the intra-aortic balloon pump (IABP) market.

Segment Review
The intra-aortic balloon pump (IABP) market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into intra-aortic balloon pump (IABP) catheter and intra-aortic balloon pump (IABP) console. Depending on indication, it is divided into coronary artery disease and chronic heart failure. As per end user, it is classified into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the intra-aortic balloon pump (IABP) console segment is expected to be the highest shareholder during the forecast period.
Depending on indication, the coronary artery disease segment is projected to account for a high share of the market by 2033.
As per end user, the hospitals segment is anticipated to acquire a high share of the market throughout the forecast period.
Region wise, North America is predicted to be the highest revenue generator by 2033.
Competition Analysis
The major players in the global intra-aortic balloon pump (IABP) market include Abbott Laboratories, Getinge AB, Maquet Cardiovascular, CardiacAssist, Inc., Teleflex Incorporated, Bard Peripheral Vascular Inc., Medtronic plc, LivaNova PLC, Terumo Corporation, and Boston Scientific Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Product
● Intra-aortic Balloon Pump (IABP) Catheter
● Intra-aortic Balloon Pump (IABP) Console
By Indication
● Coronary Artery Disease
● Chronic Heart Failure
By End User
● Hospitals
● Ambulatory Surgical Centers
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ Abbott Laboratories
○ Getinge AB
○ Maquet Cardiovascular
○ CardiacAssist, Inc.
○ Teleflex Incorporated
○ Bard Peripheral Vascular Inc.
○ Medtronic plc
○ LivaNova PLC
○ Terumo Corporation
○ Boston Scientific Corporation

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: INTRA-AORTIC BALLOON PUMP (IABP) MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Intra-aortic Balloon Pump (IABP) Catheter
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Intra-aortic Balloon Pump (IABP) Console
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: INTRA-AORTIC BALLOON PUMP (IABP) MARKET, BY INDICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Indication
5.2. Coronary Artery Disease
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Chronic Heart Failure
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: INTRA-AORTIC BALLOON PUMP (IABP) MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: INTRA-AORTIC BALLOON PUMP (IABP) MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Indication
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Intra-Aortic Balloon Pump (IABP) Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Indication
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Intra-Aortic Balloon Pump (IABP) Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Indication
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Intra-Aortic Balloon Pump (IABP) Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Indication
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Indication
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Intra-Aortic Balloon Pump (IABP) Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Indication
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Intra-Aortic Balloon Pump (IABP) Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Indication
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Intra-Aortic Balloon Pump (IABP) Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Indication
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Intra-Aortic Balloon Pump (IABP) Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Indication
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Intra-Aortic Balloon Pump (IABP) Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Indication
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Intra-Aortic Balloon Pump (IABP) Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Indication
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Indication
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Intra-Aortic Balloon Pump (IABP) Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Indication
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Intra-Aortic Balloon Pump (IABP) Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Indication
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Intra-Aortic Balloon Pump (IABP) Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Indication
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Intra-Aortic Balloon Pump (IABP) Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Indication
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Intra-Aortic Balloon Pump (IABP) Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Indication
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Intra-Aortic Balloon Pump (IABP) Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Indication
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Indication
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Intra-Aortic Balloon Pump (IABP) Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Indication
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Intra-Aortic Balloon Pump (IABP) Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Indication
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Intra-Aortic Balloon Pump (IABP) Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Indication
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Intra-Aortic Balloon Pump (IABP) Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Indication
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Getinge AB
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Maquet Cardiovascular
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. CardiacAssist, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Teleflex Incorporated
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Bard Peripheral Vascular Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Medtronic Plc
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. LivaNova PLC
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Terumo Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Boston Scientific Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments